Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells (Q40361855)
Jump to navigation
Jump to search
scientific article published on 22 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells |
scientific article published on 22 January 2017 |
Statements
1 reference
Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells (English)
1 reference
Yoshifumi Kobayashi
1 reference
Céline Gélinas
1 reference
Joseph P Dougherty
1 reference
22 January 2017
1 reference
1 reference
98
1 reference
4
1 reference
799-809
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference